Merck & Co's Options: A Look at What the Big Money Is Thinking
Merck & Co's Options: A Look at What the Big Money Is Thinking
Financial giants have made a conspicuous bullish move on Merck & Co. Our analysis of options history for Merck & Co (NYSE:MRK) revealed 11 unusual trades.
金融巨頭對默沙東採取了明顯的看好舉動。我們對默沙東的期權歷史進行分析後發現，有11筆不尋常的交易。
Delving into the details, we found 63% of traders were bullish, while 36% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $345,354, and 5 were calls, valued at $202,967.
深入研究細節，我們發現63%的交易員看好，而有36%的交易員表現出看淡的傾向。我們發現了所有交易中的6筆看跌期權交易，價值345,354美元，以及5筆看漲期權交易，價值202,967美元。
Predicted Price Range
預測價格區間
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $85.0 to $130.0 for Merck & Co during the past quarter.
分析這些合約的成交量和持倉量，似乎大戶在過去一個季度裏一直關注默沙東的股價區間爲85.0美元到130.0美元。
Analyzing Volume & Open Interest
分析成交量和未平倉合約
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
這些數據可以幫助您跟蹤Coinbase Glb期權的流動性和利益，以給定的行權價格爲基礎。
This data can help you track the liquidity and interest for Merck & Co's options for a given strike price.
這些數據可以幫助你追蹤默沙東的期權在給定行權價格上的流動性和興趣。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Merck & Co's whale activity within a strike price range from $85.0 to $130.0 in the last 30 days.
下面，我們可以觀察到近30天內，默沙東所有的鯨魚活動中，看漲和看跌期權的成交量和持倉量的變化，的行使價格區間爲85.0美元到130.0美元。
Merck & Co 30-Day Option Volume & Interest Snapshot
默沙東30天期權成交量及持倉量快照
Noteworthy Options Activity:
值得注意的期權活動：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK | PUT | TRADE | BULLISH | 01/16/26 | $18.75 | $18.1 | $18.25 | $130.00 | $182.5K | 332 | 100 |
| MRK | CALL | SWEEP | BULLISH | 09/06/24 | $1.99 | $1.98 | $1.99 | $116.00 | $49.9K | 180 | 327 |
| MRK | CALL | SWEEP | BULLISH | 01/17/25 | $8.15 | $8.05 | $8.15 | $115.00 | $40.7K | 2.1K | 50 |
| MRK | CALL | SWEEP | BEARISH | 10/18/24 | $1.86 | $1.8 | $1.81 | $120.00 | $39.8K | 12.6K | 635 |
| MRK | CALL | SWEEP | BULLISH | 09/06/24 | $1.97 | $1.96 | $1.97 | $116.00 | $37.8K | 180 | 520 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK | 看跌 | 交易 | 看好 | 01/16/26 | 18.75美元 | $18.1 | $18.25 | $130.00 | Current RSI values indicate that the stock is may be approaching overbought. | 332 | 100 |
| MRK | 看漲 | SWEEP | 看好 | 09/06/24 | $1.99 | $1.98 | $1.99 | $116.00 | 49.9千美元 | 180 | 327 |
| MRK | 看漲 | SWEEP | 看好 | 01/17/25 | $8.15 | $8.05 | $8.15 | $115.00 | $40.7K | 2.1K | 50 |
| MRK | 看漲 | SWEEP | 看淡 | 10/18/24 | $1.86 | $1.8 | $1.81 | $120.00 | $39.8K | 12.6K | 635 |
| MRK | 看漲 | SWEEP | 看好 | 09/06/24 | $1.97 | 1.96美元 | $1.97 | $116.00 | $37.8K | 180 | 520 |
About Merck & Co
關於默沙東
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
默沙東生產多種藥品，治療多種領域的疾病，包括心代謝症、癌症和感染。在癌症領域，該公司的免疫腫瘤學平台正在成爲總銷售額的主要貢獻者。該公司還具有實質性的疫苗業務，包括預防兒童疾病以及人類乳頭瘤病毒（HPV）治療。此外，默沙東出售與動物健康相關的藥品。從地理角度來看，公司銷售額的近一半來自於美國境內。
In light of the recent options history for Merck & Co, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Present Market Standing of Merck & Co
默沙東的現市場地位
- With a trading volume of 3,209,934, the price of MRK is down by -0.19%, reaching $116.38.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 59 days from now.
- 當前RSI值表明該股票可能接近超買狀態。
- 下次業績發佈將在59天后。
Professional Analyst Ratings for Merck & Co
默沙東的專業分析師評級
In the last month, 4 experts released ratings on this stock with an average target price of $138.5.
- Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Merck & Co with a target price of $145.
- Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Merck & Co, targeting a price of $142.
- An analyst from Wells Fargo persists with their Equal-Weight rating on Merck & Co, maintaining a target price of $125.
- An analyst from UBS has decided to maintain their Buy rating on Merck & Co, which currently sits at a price target of $142.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Merck & Co options trades with real-time alerts from Benzinga Pro.
期權交易存在更高的風險和潛在回報。機智的交易者通過不斷學習、調整他們的策略、監測多個因子和密切關注市場動向來控制這些風險。通過Benzinga Pro實時提醒了解最新的默沙東期權交易。